n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Retinal Degeneration in 1 studies
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.
Retinal Degeneration: A retrogressive pathological change in the retina, focal or generalized, caused by genetic defects, inflammation, trauma, vascular disease, or aging. Degeneration affecting predominantly the macula lutea of the retina is MACULAR DEGENERATION. (Newell, Ophthalmology: Principles and Concepts, 7th ed, p304)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, JS | 1 |
Kim, KA | 1 |
Yoon, YJ | 1 |
Fujikado, T | 1 |
Joo, CK | 1 |
1 other study available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Retinal Degeneration
Article | Year |
---|---|
Inhibition of cyclooxygenase-2 expression by zinc-chelator in retinal ischemia.
Topics: Animals; Chelating Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Edetic Acid; Ethylenediami | 2006 |